ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
This Quarter Return
-18.95%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$185M
AUM Growth
+$185M
(-61%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-77.75%
Top 10 Holdings %
Top 10 Hldgs %
20.06%
Holding
595
New
108
Increased
266
Reduced
153
Closed
46
Top Buys
| 1 |
Vanguard Information Technology ETF
VGT
|
$2.43M |
| 2 |
Coca-Cola
KO
|
$1.96M |
| 3 |
Bristol-Myers Squibb
BMY
|
$1.66M |
| 4 |
Verizon
VZ
|
$1.65M |
| 5 |
Colgate-Palmolive
CL
|
$1.56M |
Top Sells
| 1 |
Cardinal Health
CAH
|
$21.5M |
| 2 |
Gilead Sciences
GILD
|
$14.4M |
| 3 |
Nucor
NUE
|
$12.8M |
| 4 |
Franklin Resources
BEN
|
$12.4M |
| 5 |
Bath & Body Works
BBWI
|
$12M |
Sector Composition
| 1 | Real Estate | 18.72% |
| 2 | Healthcare | 14.49% |
| 3 | Technology | 12.76% |
| 4 | Consumer Staples | 12.63% |
| 5 | Consumer Discretionary | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Uranium Energy
UEC
$5.11B
| $110K | 0.06% |
196,177
+75,265
| +62% | +$42.2K |
|
252
Tactile Systems Technology
TCMD
$295M
| $107K | 0.06% |
2,675
+1,544
| +137% | +$61.8K |
|
|
NVRO
253
DELISTED
NEVRO CORP.
NVRO
| $105K | 0.06% |
1,050
+344
| +49% | +$34.4K |
|
254
BioMarin Pharmaceuticals
BMRN
$11.3B
| $104K | 0.06% |
1,225
+350
| +40% | +$29.7K |
|
255
Azenta
AZTA
$1.35B
| $104K | 0.06% |
3,405
+1,751
| +106% | +$53.5K |
|
256
Abbott
ABT
$230B
| $104K | 0.06% |
1,320
+571
| +76% | +$45K |
|
257
NexGen Energy
NXE
$4.5B
| $100K | 0.05% |
137,668
+46,204
| +51% | +$33.6K |
|
258
Baxter International
BAX
$12.1B
| $99K | 0.05% |
1,221
+465
| +62% | +$37.7K |
|
259
Rio Tinto
RIO
$102B
| $98K | 0.05% |
2,145
+517
| +32% | +$23.6K |
|
260
Medpace
MEDP
$13.5B
| $96K | 0.05% |
1,306
+355
| +37% | +$26.1K |
|
261
Hologic
HOLX
$14.7B
| $95K | 0.05% |
2,714
+1,230
| +83% | +$43.1K |
|
262
Veeva Systems
VEEV
$44.4B
| $94K | 0.05% |
603
-99
| -14% | -$15.4K |
|
263
Intellia Therapeutics
NTLA
$1.26B
| $92K | 0.05% |
7,526
+3,741
| +99% | +$45.7K |
|
264
Ingersoll Rand
IR
$30.8B
| $92K | 0.05% |
+3,719
| New | +$92K |
|
|
HMSY
265
DELISTED
HMS Holdings Corp.
HMSY
| $91K | 0.05% |
3,617
+1,165
| +48% | +$29.3K |
|
266
3D Systems Corporation
DDD
$263M
| $91K | 0.05% |
11,818
+4,858
| +70% | +$37.4K |
|
267
CRISPR Therapeutics
CRSP
$4.82B
| $91K | 0.05% |
2,148
+1,254
| +140% | +$53.1K |
|
268
Artivion
AORT
$2.04B
| $91K | 0.05% |
5,375
+2,171
| +68% | +$36.8K |
|
|
NVTA
269
DELISTED
Invitae Corporation
NVTA
| $90K | 0.05% |
6,556
+2,465
| +60% | +$33.8K |
|
270
Philip Morris
PM
$254B
| $90K | 0.05% |
1,231
+1,130
| +1,119% | +$82.6K |
|
271
AbbVie
ABBV
$374B
| $89K | 0.05% |
1,171
+1,075
| +1,120% | +$81.7K |
|
272
BHP
BHP
$142B
| $85K | 0.05% |
2,319
+599
| +35% | +$22K |
|
273
Globus Medical
GMED
$7.94B
| $84K | 0.05% |
1,973
+1,100
| +126% | +$46.8K |
|
|
NSTG
274
DELISTED
NanoString Technologies, Inc.
NSTG
| $82K | 0.04% |
3,389
+649
| +24% | +$15.7K |
|
275
Novanta
NOVT
$4.05B
| $81K | 0.04% |
1,011
+418
| +70% | +$33.5K |
|